Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST

PURPOSE: The development of osteosarcoma therapeutics has been challenging, in part because of the lack of appropriate criteria to evaluate responses. We developed a novel criteria in a clinical trial of radium-223 dichloride ((223)RaCl(2)) for response assessment in osteosarcoma, NAFCIST (Na(18)F P...

Descripción completa

Detalles Bibliográficos
Autores principales: Kairemo, Kalevi, Rohren, Eric M, Anderson, Pete M, Ravizzini, Gregory, Rao, Arvind, Macapinlac, Homer A, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435244/
https://www.ncbi.nlm.nih.gov/pubmed/30962954
http://dx.doi.org/10.1136/esmoopen-2018-000439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435244/
https://www.ncbi.nlm.nih.gov/pubmed/30962954
http://dx.doi.org/10.1136/esmoopen-2018-000439

Ejemplares similares